Prader-Willi Syndrome
Overview
Plain-Language Overview
Prader-Willi Syndrome is a rare genetic disorder that affects the brain and several body systems. It primarily impacts the hypothalamus, a part of the brain that controls hunger, growth, and hormone regulation. People with this condition often have a constant feeling of hunger, leading to overeating and obesity. Other common features include low muscle tone, delayed development, and learning difficulties. The syndrome also causes distinctive facial features and behavioral problems. Because it affects multiple systems, it requires careful medical monitoring throughout life.
Clinical Definition
Prader-Willi Syndrome is a complex genetic disorder caused by the loss of function of paternally expressed genes on chromosome 15q11-q13, most commonly due to a paternal deletion, maternal uniparental disomy, or imprinting defects. The core pathology involves hypothalamic dysfunction leading to hyperphagia, growth hormone deficiency, hypogonadism, and impaired temperature regulation. Clinically, it presents with neonatal hypotonia, feeding difficulties in infancy, followed by insatiable appetite and obesity in childhood. Additional features include intellectual disability, behavioral problems such as temper outbursts, and characteristic facial dysmorphisms. The syndrome is significant due to its lifelong impact on growth, metabolism, and neurodevelopment.
Inciting Event
Genetic abnormalities including paternal deletion, maternal uniparental disomy, or imprinting defects on chromosome 15q11-q13.
No environmental or infectious triggers are implicated in disease onset.
Latency Period
Symptoms typically begin in the neonatal period with hypotonia and poor feeding.
Hyperphagia and obesity develop gradually during early childhood, often by age 2 to 6 years.
Neurodevelopmental and behavioral symptoms become more apparent in early childhood.
Diagnostic Delay
Early hypotonia and feeding difficulties may be misattributed to non-specific neonatal conditions.
Lack of awareness of the syndrome’s progressive hyperphagia delays diagnosis until obesity develops.
Behavioral and cognitive symptoms may be mistaken for autism spectrum disorder or other neurodevelopmental disorders.
Genetic testing may be delayed due to limited access or low clinical suspicion.
Clinical Presentation
Signs & Symptoms
Neonatal hypotonia with poor suck and feeding difficulties
Hyperphagia leading to severe obesity in early childhood
Developmental delay and intellectual disability
Hypogonadism causing delayed or incomplete puberty
Behavioral problems including temper tantrums and obsessive-compulsive features
History of Present Illness
Neonatal history of severe hypotonia and poor suckling leading to feeding difficulties.
Progressive onset of hyperphagia with an insatiable appetite causing rapid weight gain in early childhood.
Development of mild to moderate intellectual disability and behavioral problems such as temper tantrums and obsessive-compulsive features.
Signs of hypogonadism including delayed or incomplete puberty.
Sleep disturbances and excessive daytime sleepiness are common.
Past Medical History
History of neonatal hypotonia and failure to thrive despite adequate feeding.
Previous episodes of respiratory infections due to hypotonia-related complications.
No prior significant medical conditions unrelated to the syndrome.
Family History
Usually sporadic cases with no family history due to de novo genetic events.
Rare familial cases may occur due to inherited imprinting center defects.
No consistent association with other inherited syndromes.
Physical Exam Findings
Hypotonia with decreased muscle tone in infancy
Short stature and small hands and feet
Almond-shaped eyes and narrow bifrontal diameter
Obesity developing in early childhood due to hyperphagia
Cryptorchidism in males
Thin upper lip and downturned mouth
Diagnostic Workup
Diagnostic Criteria
Diagnosis is established by clinical suspicion based on hallmark features including hypotonia, feeding difficulties in infancy, followed by hyperphagia and obesity, developmental delay, and characteristic facial features. Confirmation requires genetic testing demonstrating abnormalities in the 15q11-q13 region, such as paternal deletion, maternal uniparental disomy, or imprinting defects. Methylation analysis is the preferred initial test as it detects all major genetic causes. Additional tests may include fluorescence in situ hybridization (FISH) or chromosomal microarray to identify deletions.
Pathophysiology
Key Mechanisms
Loss of paternal expression of imprinted genes on chromosome 15q11-q13 leads to hypothalamic dysfunction.
Hypothalamic dysfunction causes impaired satiety regulation resulting in hyperphagia and obesity.
Deficient secretion of growth hormone and other pituitary hormones contributes to short stature and hypogonadism.
Abnormalities in neurodevelopmental pathways cause intellectual disability and behavioral problems.
Impaired autonomic regulation leads to temperature instability and reduced pain sensitivity.
| Involvement | Details |
|---|---|
| Organs | Hypothalamus is critically involved due to genetic abnormalities causing impaired appetite regulation and endocrine dysfunction. |
Pituitary gland dysfunction leads to growth hormone deficiency and other hormonal imbalances. | |
Brain abnormalities contribute to intellectual disability and behavioral problems. | |
| Tissues | Adipose tissue is increased due to hyperphagia and decreased energy expenditure, leading to obesity. |
Muscle tissue is hypotonic and underdeveloped, contributing to motor delays and weakness. | |
| Cells | Hypothalamic neurons are dysfunctional, leading to impaired satiety signaling and endocrine abnormalities in Prader-Willi syndrome. |
| Chemical Mediators | Ghrelin levels are elevated, contributing to hyperphagia and obesity in Prader-Willi syndrome. |
Growth hormone deficiency is common and contributes to short stature and abnormal body composition. |
Treatments
Pharmacological Treatments
Growth hormone
- Mechanism:
Stimulates linear growth and improves body composition by increasing muscle mass and decreasing fat mass.
- Side effects:
Edema
Joint pain
Increased intracranial pressure
- Clinical role:
First-line
Psychotropic medications
- Mechanism:
Modulate neurotransmitter systems to manage behavioral problems such as temper outbursts and obsessive-compulsive features.
- Side effects:
Sedation
Weight gain
Extrapyramidal symptoms
- Clinical role:
Adjunctive
Non-pharmacological Treatments
Strict environmental control with supervised access to food to prevent hyperphagia and obesity.
Behavioral therapy to address temper tantrums, compulsive behaviors, and improve social skills.
Nutritional counseling to maintain a balanced, calorie-restricted diet.
Physical therapy to improve hypotonia and motor development.
Early developmental interventions including speech and occupational therapy.
Prevention
Pharmacological Prevention
Growth hormone therapy to improve body composition and height
Metformin to manage insulin resistance and prevent diabetes
Melatonin for sleep disturbances
Psychotropic medications for behavioral and psychiatric symptoms
Hormone replacement therapy for hypogonadism
Non-pharmacological Prevention
Strict dietary supervision to prevent hyperphagia and obesity
Regular physical activity to improve muscle tone and metabolic health
Early developmental interventions including physical and occupational therapy
Behavioral therapy to manage compulsive behaviors
Sleep studies and respiratory support to prevent apnea complications
Outcome & Complications
Complications
Severe obesity-related complications including cardiovascular disease
Respiratory failure from obstructive sleep apnea
Type 2 diabetes mellitus with associated microvascular and macrovascular damage
Gastric rupture due to uncontrolled hyperphagia
Hypoventilation syndrome from central and peripheral respiratory control abnormalities
| Short-term Sequelae | Long-term Sequelae |
|---|---|
|
|
Differential Diagnoses
Prader-Willi Syndrome versus Angelman Syndrome
Prader-Willi Syndrome | Angelman Syndrome |
|---|---|
Paternal deletion or uniparental disomy of chromosome 15q11-q13 | Maternal deletion or mutation of chromosome 15q11-q13 |
Loss of expression of paternally imprinted genes in 15q11-q13 region | UBE3A gene mutation or deletion |
Mild to moderate intellectual disability with hyperphagia and hypotonia | Severe intellectual disability with frequent laughter and ataxia |
Methylation analysis showing loss of paternal allele | Methylation analysis showing loss of maternal allele |
Prader-Willi Syndrome versus Bardet-Biedl Syndrome
Prader-Willi Syndrome | Bardet-Biedl Syndrome |
|---|---|
Usually sporadic with imprinting defects or uniparental disomy | Autosomal recessive inheritance |
Abnormal methylation or deletion on chromosome 15q11-q13 | No specific methylation abnormalities on chromosome 15 |
Neonatal hypotonia and early childhood hyperphagia without polydactyly | Progressive retinal dystrophy and polydactyly |
Methylation studies or FISH showing 15q11-q13 abnormalities | Genetic testing showing mutations in BBS genes |
Prader-Willi Syndrome versus Down Syndrome
Prader-Willi Syndrome | Down Syndrome |
|---|---|
Imprinting or deletion abnormalities on chromosome 15 | Trisomy 21 due to nondisjunction |
Normal karyotype with methylation defects on chromosome 15 | Karyotype showing trisomy 21 |
Hypotonia and hyperphagia without typical Down syndrome facies | Characteristic facial features and congenital heart defects |
Methylation or FISH confirming 15q11-q13 deletion or uniparental disomy | Chromosomal analysis confirming trisomy 21 |
Prader-Willi Syndrome versus Hypothalamic Obesity
Prader-Willi Syndrome | Hypothalamic Obesity |
|---|---|
No history of hypothalamic damage; genetic cause | History of hypothalamic injury or tumor |
Progressive obesity starting in early childhood with developmental delay | Rapid onset obesity after hypothalamic insult |
Abnormal methylation or deletion on chromosome 15q11-q13 | Normal genetic testing; obesity secondary to hypothalamic dysfunction |
Prader-Willi Syndrome versus Fragile X Syndrome
Prader-Willi Syndrome | Fragile X Syndrome |
|---|---|
Imprinting defect or deletion on chromosome 15q11-q13 | X-linked dominant inheritance with CGG repeat expansion in FMR1 gene |
Hypotonia, hyperphagia, and mild to moderate intellectual disability | Intellectual disability with prominent behavioral features and macroorchidism |
Methylation studies or FISH showing abnormalities in 15q11-q13 | PCR showing CGG repeat expansion in FMR1 gene |